Elevated IL-6 levels (>5 pg/mL) were strongly associated with CAD progression, as reflected by the nearly 3-fold increased risk in patients with elevated levels (adjusted OR = 3.051, P = .023). The gene discussed is IL6; the disease is coronary artery disorder.